![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Shuwen Biotech’s COVID-19 Test Receives CE Mark Certification
Shuwen Biotech’s COVID-19 Test Receives CE Mark Certification
![](https://www.fdanews.com/ext/resources/test/Drug-Images4/China_Map.gif?t=1478215210&width=430)
Deqing, China-based Shuwen Biotech has received the CE mark for its real-time reverse transcription polymerase chain reaction (RT-PCR) test kit for COVID-19.
The test, which works with nasal, nasopharyngeal and oropharyngeal swabs can distinguish between coronavirus infections and other closely related viruses.
Shuwen said its test has been validated on multiple real-time PCR platforms, including the ABI 7500, ABI 7500 Fast, QuantStudio Dx, Cobas Z480, LightCycler 480 II, CFX96, Rotor-Gene Q and SLAN-96S.
The kits are immediately available for distribution in Europe and other territories recognizing CE certification, the company said.
Upcoming Events
-
21Oct